These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 25157181)
1. Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis. Rodríguez-Díez E; Quereda V; Bellutti F; Prchal-Murphy M; Partida D; Eguren M; Kollmann K; Gómez de Cedrón M; Dubus P; Cañamero M; Martínez D; Sexl V; Malumbres M Blood; 2014 Oct; 124(15):2380-90. PubMed ID: 25157181 [TBL] [Abstract][Full Text] [Related]
2. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors. Parry D; Mahony D; Wills K; Lees E Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865 [TBL] [Abstract][Full Text] [Related]
3. CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms. Ruas M; Gregory F; Jones R; Poolman R; Starborg M; Rowe J; Brookes S; Peters G Mol Cell Biol; 2007 Jun; 27(12):4273-82. PubMed ID: 17420273 [TBL] [Abstract][Full Text] [Related]
4. CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia. Jena N; Sheng J; Hu JK; Li W; Zhou W; Lee G; Tsichlis N; Pathak A; Brown N; Deshpande A; Luo C; Hu GF; Hinds PW; Van Etten RA; Hu MG Leukemia; 2016 May; 30(5):1033-43. PubMed ID: 26707936 [TBL] [Abstract][Full Text] [Related]
5. Ara-c induces cell cycle G1/S arrest by inducing upregulation of the INK4 family gene or directly inhibiting the formation of the cell cycle-dependent complex CDK4/cyclin D1. Sun F; Li N; Tong X; Zeng J; He S; Gai T; Bai Y; Liu L; Lu K; Shen J; Han M; Lu C; Dai F Cell Cycle; 2019 Sep; 18(18):2293-2306. PubMed ID: 31322047 [TBL] [Abstract][Full Text] [Related]
6. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. Ramsey MR; Krishnamurthy J; Pei XH; Torrice C; Lin W; Carrasco DR; Ligon KL; Xiong Y; Sharpless NE Cancer Res; 2007 May; 67(10):4732-41. PubMed ID: 17510401 [TBL] [Abstract][Full Text] [Related]
7. Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression. Quereda V; Martinalbo J; Dubus P; Carnero A; Malumbres M Oncogene; 2007 Dec; 26(55):7665-74. PubMed ID: 17599058 [TBL] [Abstract][Full Text] [Related]
8. Inducible deletion of CDK4 and CDK6 - deciphering CDK4/6 inhibitor effects in the hematopoietic system. Maurer B; Brandstoetter T; Kollmann S; Sexl V; Prchal-Murphy M Haematologica; 2021 Oct; 106(10):2624-2632. PubMed ID: 32855282 [TBL] [Abstract][Full Text] [Related]
9. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Reynisdóttir I; Polyak K; Iavarone A; Massagué J Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471 [TBL] [Abstract][Full Text] [Related]
10. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Hirai H; Roussel MF; Kato JY; Ashmun RA; Sherr CJ Mol Cell Biol; 1995 May; 15(5):2672-81. PubMed ID: 7739547 [TBL] [Abstract][Full Text] [Related]
11. CDK6 as a key regulator of hematopoietic and leukemic stem cell activation. Scheicher R; Hoelbl-Kovacic A; Bellutti F; Tigan AS; Prchal-Murphy M; Heller G; Schneckenleithner C; Salazar-Roa M; Zöchbauer-Müller S; Zuber J; Malumbres M; Kollmann K; Sexl V Blood; 2015 Jan; 125(1):90-101. PubMed ID: 25342715 [TBL] [Abstract][Full Text] [Related]
12. INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors. Li Q; Jiang B; Guo J; Shao H; Del Priore IS; Chang Q; Kudo R; Li Z; Razavi P; Liu B; Boghossian AS; Rees MG; Ronan MM; Roth JA; Donovan KA; Palafox M; Reis-Filho JS; de Stanchina E; Fischer ES; Rosen N; Serra V; Koff A; Chodera JD; Gray NS; Chandarlapaty S Cancer Discov; 2022 Feb; 12(2):356-371. PubMed ID: 34544752 [TBL] [Abstract][Full Text] [Related]
13. Biochemical characterization of p16INK4- and p18-containing complexes in human cell lines. Ragione FD; Russo GL; Oliva A; Mercurio C; Mastropietro S; Pietra VD; Zappia V J Biol Chem; 1996 Jul; 271(27):15942-9. PubMed ID: 8663131 [TBL] [Abstract][Full Text] [Related]
14. Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Jeffrey PD; Tong L; Pavletich NP Genes Dev; 2000 Dec; 14(24):3115-25. PubMed ID: 11124804 [TBL] [Abstract][Full Text] [Related]
15. Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors. Fink JR; LeBien TW Exp Hematol; 2001 Apr; 29(4):490-8. PubMed ID: 11301189 [TBL] [Abstract][Full Text] [Related]
16. A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target. Franceschini N; Gaeta R; Krimpenfort P; Briaire-de Bruijn I; Kruisselbrink AB; Szuhai K; Palubeckaitė I; Cleton-Jansen AM; Bovée JVMG Lab Invest; 2022 Apr; 102(4):391-400. PubMed ID: 34921235 [TBL] [Abstract][Full Text] [Related]
17. Differential Regulation of Cancer Progression by CDK4/6 Plays a Central Role in DNA Replication and Repair Pathways. Dai M; Boudreault J; Wang N; Poulet S; Daliah G; Yan G; Moamer A; Burgos SA; Sabri S; Ali S; Lebrun JJ Cancer Res; 2021 Mar; 81(5):1332-1346. PubMed ID: 33372040 [TBL] [Abstract][Full Text] [Related]
18. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. Sotillo R; Dubus P; Martín J; de la Cueva E; Ortega S; Malumbres M; Barbacid M EMBO J; 2001 Dec; 20(23):6637-47. PubMed ID: 11726500 [TBL] [Abstract][Full Text] [Related]
19. An essential role for Ink4 and Cip/Kip cell-cycle inhibitors in preventing replicative stress. Quereda V; Porlan E; Cañamero M; Dubus P; Malumbres M Cell Death Differ; 2016 Mar; 23(3):430-41. PubMed ID: 26292757 [TBL] [Abstract][Full Text] [Related]
20. A defect of the INK4-Cdk4 checkpoint and Myc collaborate in blastoid mantle cell lymphoma-like lymphoma formation in mice. Vincent-Fabert C; Fiancette R; Rouaud P; Baudet C; Truffinet V; Magnone V; Guillaudeau A; Cogné M; Dubus P; Denizot Y Am J Pathol; 2012 Apr; 180(4):1688-701. PubMed ID: 22326754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]